✦ LIBER ✦

Metronidazole and interstitial implantation in the treatment of extensive recurrent head and neck cancers

✍ Scribed by Leo E. Orr; Ajmel Puthawala; A.M. Nisar Syed; Peter A. Fleming

Publisher: Elsevier Science
Year: 1979
Tongue: English
Weight: 100 KB
Volume: 5
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(79)90357-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metronidazole and interstitial implantat

Metronidazole and interstitial implantation in the treatment of extensive recurrent head and neck cancers

✍ Leo E. Orr; Ajmel Puthawala; A. M. Nisar Syed; Peter A. Fleming 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB 👁 2 views

Twenty-three patients with recurrent or persistent epidermoid carcinoma of the oral cavity, all of whom had failed primary antitumor therapy, were treated with interstitial irradiation and a radiosensitizer. Such primary therapy had included radical surgery, external radiation therapy, or a combinat

Treatment of recurrent head and neck can

Treatment of recurrent head and neck cancerrs with afterloading interstitial 192 iridium implants

✍ A.M.N. Syed; F.W. George III; A. Puthawala; A. Fleming 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Interstitial misonidazole in the treatme

Interstitial misonidazole in the treatment of head and neck cancer

✍ Rossall Sealy; Jan Korrubel; Stephen Cridland; Gerry Blekkenhorst 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Recurrent head and neck cancer: The resu

Recurrent head and neck cancer: The results of treatment

✍ R. G. Williams 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

## Abstract A study of 144 patients with cancer of the head and neck showed that 67 (46 per cent) developed recurrent cancer. Radical second treatment, almost exclusively by surgery, secured an 11 out of 67 or 16 per cent crude 5-year survival rate for recurrent head and neck cancer. Further analys

Interstitial low-dose-rate brachytherapy

Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies

✍ Laval Grimard; Bernd Esche; André Lamothe; Joanna Cygler; Johanna Spaans 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 1 views

Background. Recurrent head and neck malignancies are therapeutically challenging. Brachytherapy is a retreatment alternative to external-beam radiation therapy (EBRT). Methods. Patients receiving brachytherapy during 1987-2004 for recurrent head and neck cancer were identified. Tumor and treatment

Second primary cancers of the head and n

Second primary cancers of the head and neck following treatment of initial primary head and neck cancers

✍ Robert G. Parker; James E. Enstrom 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 485 KB